Cost-Utility Analysis of the germline BRCA testing in Women with epithelial ovarian cancer without family history in Spain
Congress: ISPOR
Year: 2018
Desease: Cancer
Subject: Cost study
Subcategory:Cost-utility analysis
Objective: germline BRCA1 and BRCA2 gene mutations (gBRCA1/2m) are associated with an increased risk of ovarian cancer (OC) and breast cancer (BC). This study estimates the long-term efficiency of providing germline BRCA testing (gBRCAt) in women with high-grade epithelial nonmucinous OC without a family history of OC or BC in Spain (index population) and the subsequent evaluation and management of their relatives who have gBRCA1/2m.